-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
NexImmune, Inc. quarterly/annual Revenues history and growth rate from 2020 to 2021.
- NexImmune, Inc. Revenues for the quarter ending September 30, 2022 was $0.000.
- NexImmune, Inc. Revenues for the twelve months ending September 30, 2022 was $0.000.
- NexImmune, Inc. annual Revenues for 2021 was $0.000.